Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0917801 (
insomnia
)
10,606
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
TAK-375 (Ramelteon), a melatonin
ML1
/MT1 receptor agonist for the potential treatment of primary
insomnia
, is being developed by Takeda. Takeda submitted an NDA to the FDA for TAK-375 in September 2004.
...
PMID:TAK-375 Takeda. 1567 11
